The Rising Prevalence of Skin Cancer in Canada

May 26, 2022

Digital Healthcare 101: What is Digital Medicine?

May 10, 2022

New Chapter in Digital Health: e-Prescribing

March 17, 2022

Improving Medication Adherence

March 8, 2022

How Pharmacists Can Better Manage Take-Home Cancer Drugs

February 22, 2022
Take-home cancer drugs are the norm. But how can pharmacists adapt to this while limiting the risk for medication errors? Read our blog for more.

Cancer Prevention: Who’s at Risk and When to get Screened

February 4, 2022

Top Topics Healthcare Providers Want to Learn More About Post-Pandemic

September 9, 2021
MDBriefCase recently conducted a survey among Canadian members to assess priorities for continuing education as they manage patients through the COVID-19 pandemic. Almost 62 per cent ranked mental health as a priority area, with diabetes a close second (61 per cent), followed by heart conditions (59.5 per cent) and dementia/other neurological conditions (52.9 per cent). Visit the MDBriefCase course catalogue for our full offering of educational programs in these and other therapeutic areas.

Think Research Completes Acquisition of MDBriefCase, an International Provider of Accredited Digital Education to Clinicians

January 29, 2021
Original press release posted on CNW.Jan 29, 2021, 13:00 ET Strategic acquisition positions Think Research to educate clinicians internationally on the latest evidence and protocols and also to provide them with the digital tools required to immediately deploy that knowledge into their practice, thereby improving patient care, safety and outcomes Combined, Think Research and MDBriefCase reach a network of nearly 300,000 global healthcare professionals in Canada, Europe, Australia, Africa and the Middle East With the acquisition of MDBriefCase, trailing pro forma revenue grows to more than $36M TORONTO, Jan. 29, 2021 /CNW/ – Think Research Corporation (TSXV: THNK) or (the “Company” or “Think Research“), a company focused on transforming healthcare through integrated digital health solutions, today announced that it has completed the previously announced definitive agreement to acquire all of the issued and outstanding shares of MDBriefCase Group Inc. (“MDBriefCase“), a leading provider of online continuing medical education (“CME“) and professional development solutions for clinicians and a portfolio company of Persistence Capital Partners. The acquisition was made for an aggregate purchase price of $25.3M in Think Research shares and cash, and a total enterprise value of $28.5M. Sachin Aggarwal, CEO of Think Research, said, “This is a highly strategic acquisition for Think Research and we are eager to get going on integrating MDBriefCase […]